HFMA Comments on CY 2021 OPPS/ASC Proposed Rule
HFMA submitted comments to CMS on the CY 2021 OPPS/ASC proposed rule, published in the August 12, 2020, Federal Register. In the letter, comments pertained to the proposals related to:
- Separately Payable Drugs Provided by 340B Hospitals
- Proposed changes to the Inpatient Only (IPO) List
- Proposed Ambulatory Surgical Center (ASC) Payment and Comment Indicator
- Proposed Prior Authorization Process Requirements for Certain Outpatient Hospital Department Services